Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective
Authors
Keywords
-
Journal
ARCHIVES OF PHARMACAL RESEARCH
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-05
DOI
10.1007/s12272-020-01301-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China
- (2020) Jin-jin Zhang et al. ALLERGY
- Coronavirus infections and immune responses
- (2020) Geng Li et al. JOURNAL OF MEDICAL VIROLOGY
- Abnormal Coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
- (2020) Ning Tang et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Favipiravir, an anti-influenza drug against life-threatening RNA virus infections
- (2020) Kimiyasu Shiraki et al. PHARMACOLOGY & THERAPEUTICS
- Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury
- (2020) Yingxia Liu et al. Science China-Life Sciences
- Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19
- (2020) Markus Hoffmann et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review
- (2020) Jaume Alijotas-Reig et al. AUTOIMMUNITY REVIEWS
- Lymphopenia in COVID‐19: Therapeutic Opportunities
- (2020) Nazanin Fathi et al. CELL BIOLOGY INTERNATIONAL
- Angiotensin Converting Enzyme 2: A Double-Edged Sword
- (2020) Kaiming Wang et al. CIRCULATION
- COVID-19 and the Heart
- (2020) Akbarshakh Akhmerov et al. CIRCULATION RESEARCH
- Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System
- (2020) Mahmoud Gheblawi et al. CIRCULATION RESEARCH
- The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China
- (2020) Wen Zhang et al. CLINICAL IMMUNOLOGY
- Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment
- (2020) Mehmet Soy et al. CLINICAL RHEUMATOLOGY
- COVID-19 cytokine storm: The anger of inflammation
- (2020) Mehdi Mahmudpour et al. CYTOKINE
- The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system
- (2020) Francesca Coperchini et al. CYTOKINE & GROWTH FACTOR REVIEWS
- IL-6: Relevance for immunopathology of SARS-CoV-2
- (2020) E.O. Gubernatorova et al. CYTOKINE & GROWTH FACTOR REVIEWS
- COVID 19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease
- (2020) Daniela Tomasoni et al. EUROPEAN JOURNAL OF HEART FAILURE
- Prevention and treatment of COVID‐19 disease by controlled modulation of innate immunity
- (2020) Virgil Schijns et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The pivotal link between ACE2 deficiency and SARS-CoV-2 infection
- (2020) Paolo Verdecchia et al. European Journal of Internal Medicine
- Does lopinavir measure up in the treatment of Covid-19?
- (2020) Sheila A Doggrell EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Pathophysiology of COVID-19: Why Children Fare Better than Adults?
- (2020) Nitin Dhochak et al. INDIAN JOURNAL OF PEDIATRICS
- Cytokine Release Syndrome in COVID-19 Patients, A New Scenario for an Old Concern: The Fragile Balance between Infections and Autoimmunity
- (2020) Andrea Picchianti Diamanti et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- COVID-19 as an Acute Inflammatory Disease
- (2020) Rose H. Manjili et al. JOURNAL OF IMMUNOLOGY
- COVID‐19 and Renin‐Angiotensin system inhibition – role of angiotensin converting enzyme 2 (ACE2) ‐ Is there any scientific evidence for controversy?
- (2020) Aneta Aleksova et al. JOURNAL OF INTERNAL MEDICINE
- COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up
- (2020) Behnood Bikdeli et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Potential of heparin and nafamostat combination therapy for COVID‐19
- (2020) Hidesaku Asakura et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID‐19
- (2020) Claire S Whyte et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Lopinavir–ritonavir in severe COVID-19
- (2020) Hannah Stower NATURE MEDICINE
- Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
- (2020) Muthiah Vaduganathan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biochemical indicators of coronavirus disease 2019 exacerbation and the clinical implications
- (2020) Peng-jiao An et al. PHARMACOLOGICAL RESEARCH
- Platelet functions and activities as potential hematologic parameters related to Coronavirus Disease 2019 (Covid-19)
- (2020) Francesca Salamanna et al. PLATELETS
- Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research
- (2020) Mahesh V. Madhavan et al. THROMBOSIS AND HAEMOSTASIS
- Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence
- (2020) Yu-chen Cao et al. Travel Medicine and Infectious Disease
- An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies
- (2020) Kuldeep Dhama et al. Travel Medicine and Infectious Disease
- Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB
- (2020) Juan Simon Rico-Mesa et al. Current Cardiology Reports
- Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS-CoV-2 in Covid-19: Key Therapeutic Targets?
- (2020) Jean-Michel Sallenave et al. Frontiers in Immunology
- Fighting the Host Reaction to SARS-COv-2 in Critically Ill Patients: The Possible Contribution of Off-Label Drugs
- (2020) Stefania Scala et al. Frontiers in Immunology
- Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
- (2020) Jia Liu et al. Cell Discovery
- COVID-19 infection in a patient with multiple sclerosis treated with fingolimod
- (2020) Mahdi Barzegar et al. Neurology-Neuroimmunology & Neuroinflammation
- COVID-19 Pandemic: Cardiovascular Complications and Future Implications
- (2020) Dhrubajyoti Bandyopadhyay et al. American Journal of Cardiovascular Drugs
- Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: A novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis
- (2020) Brandon Michael Henry et al. CLINICA CHIMICA ACTA
- Lopinavir-Ritonavir in the Treatment of COVID-19: A Dynamic Systematic Benefit-Risk Assessment
- (2020) Vicki Osborne et al. DRUG SAFETY
- Basic immunology may lead to translational therapeutic rationale: SARS‐CoV‐2 and rheumatic diseases
- (2020) Elisa Gremese et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?
- (2020) Massimo Imazio et al. HEART
- COVID 19: a clue from innate immunity
- (2020) Domenico Birra et al. IMMUNOLOGIC RESEARCH
- The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of “inflame-aging”
- (2020) Gholam Hossein Meftahi et al. INFLAMMATION RESEARCH
- Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids
- (2020) Amene Saghazadeh et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Immunopathology of SARS-CoV-2 Infection: Immune Cells and Mediators, Prognostic Factors, and Immune-Therapeutic Implications
- (2020) Alessandro Allegra et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?
- (2020) Bingwen Liu et al. JOURNAL OF AUTOIMMUNITY
- Antithrombotic Therapies in COVID-19 Disease: a Systematic Review
- (2020) Edward Maldonado et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- SARS-CoV-2 as a Factor to Disbalance the Renin–Angiotensin System: A Suspect in the Case of Exacerbated IL-6 Production
- (2020) Rafael Franco et al. JOURNAL OF IMMUNOLOGY
- The pathogenesis and treatment of the `Cytokine Storm' in COVID-19
- (2020) Qing Ye et al. JOURNAL OF INFECTION
- Cytokine storm syndrome in coronavirus disease 2019: A narrative review
- (2020) Y.‐M. Gao et al. JOURNAL OF INTERNAL MEDICINE
- Cytokine storm and leukocyte changes in mild versus severe SARS‐CoV‐2 infection: Review of 3939 COVID‐19 patients in China and emerging pathogenesis and therapy concepts
- (2020) Jin Wang et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Novel therapeutic approaches for treatment of COVID-19
- (2020) Nikoo Hossein-khannazer et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Two hits to the renin‐angiotensin system may play a key role in severe COVID ‐19
- (2020) Yu‐Hsin Tseng et al. KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
- Neutrophil Extracellular Traps (NETs) and Damage-Associated Molecular Patterns (DAMPs): Two Potential Targets for COVID-19 Treatment
- (2020) Sebastiano Cicco et al. MEDIATORS OF INFLAMMATION
- Extrapulmonary manifestations of COVID-19
- (2020) Aakriti Gupta et al. NATURE MEDICINE
- Thromboinflammation in COVID-19 acute lung injury
- (2020) William Beau Mitchell Paediatric Respiratory Reviews
- COVID-19 and the Immune System
- (2020) J PACES et al. PHYSIOLOGICAL RESEARCH
- Use of remdesivir for patients with Covid-19: a review article
- (2020) Thomás Cavalcanti Pires de Azevedo et al. Revista da Associacao Medica Brasileira
- Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19
- (2020) Wei Luo et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- A Review on Remdesivir: A Possible Promising Agent for the Treatment of COVID-19
- (2020) Seyed MohammadReza Hashemian et al. Drug Design Development and Therapy
- Severe COVID-19 infection in a patient with multiple sclerosis treated with fingolimod
- (2020) Christian Foerch et al. Multiple Sclerosis and Related Disorders
- Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19
- (2020) Rafael B. Polidoro et al. Frontiers in Immunology
- Flattening the COVID-19 Curve With Natural Killer Cell Based Immunotherapies
- (2020) Marisa Market et al. Frontiers in Immunology
- Targeting the Immune System for Pulmonary Inflammation and Cardiovascular Complications in COVID-19 Patients
- (2020) Serena Colafrancesco et al. Frontiers in Immunology
- The COVID-19 Cytokine Storm; What We Know So Far
- (2020) Dina Ragab et al. Frontiers in Immunology
- The four horsemen of a viral Apocalypse: The pathogenesis of SARS-CoV-2 infection (COVID-19)
- (2020) Pere Domingo et al. EBioMedicine
- COVID-19: unravelling the clinical progression of nature’s virtually perfect biological weapon
- (2020) Giuseppe Lippi et al. Annals of Translational Medicine
- Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategies
- (2020) Alessandro Allegra et al. ANNALS OF HEMATOLOGY
- Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: Therapeutic implications
- (2020) Nehla Banu et al. LIFE SCIENCES
- Emerging role of IL-6 and NLRP3 inflammasome as potential therapeutic targets to combat COVID-19: Role of lncRNAs in cytokine storm modulation
- (2020) Alireza Paniri et al. LIFE SCIENCES
- COVID-19: Review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking
- (2020) Giuseppe Magro VIRUS RESEARCH
- FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy
- (2020) Sylwester Drożdżal et al. DRUG RESISTANCE UPDATES
- Severe Acute Respiratory Syndrome Coronavirus Viroporin 3a Activates the NLRP3 Inflammasome
- (2019) I-Yin Chen et al. Frontiers in Microbiology
- Recommendations for the management of hemophagocytic lymphohistiocytosis in adults
- (2019) Paul La Rosée et al. BLOOD
- Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir
- (2019) Egor Tchesnokov et al. Viruses-Basel
- Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
- (2017) Rudragouda Channappanavar et al. Seminars in Immunopathology
- Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice
- (2016) Rudragouda Channappanavar et al. Cell Host & Microbe
- ACE2 deficiency worsens epicardial adipose tissue inflammation and cardiac dysfunction in response to diet-induced obesity
- (2015) Vaibhav B. Patel et al. DIABETES
- ACE2 and Ang-(1–7) protect endothelial cell function and prevent early atherosclerosis by inhibiting inflammatory response
- (2015) Yue-Hui Zhang et al. INFLAMMATION RESEARCH
- Angiotensin-converting enzyme 2 and angiotensin 1–7: novel therapeutic targets
- (2014) Fan Jiang et al. Nature Reviews Cardiology
- Type 2 alveolar cells are stem cells in adult lung
- (2013) Christina E. Barkauskas et al. JOURNAL OF CLINICAL INVESTIGATION
- Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: A positive feedback mechanism in the RAS
- (2013) Vaibhav B. Patel et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- RIG-I and MDA-5 Detection of Viral RNA-dependent RNA Polymerase Activity Restricts Positive-Strand RNA Virus Replication
- (2013) Andrei Nikonov et al. PLoS Pathogens
- PAMPs and DAMPs: signal 0s that spur autophagy and immunity
- (2012) Daolin Tang et al. IMMUNOLOGICAL REVIEWS
- Neutrophil Extracellular Traps: Double-Edged Swords of Innate Immunity
- (2012) M. J. Kaplan et al. JOURNAL OF IMMUNOLOGY
- Structural Basis for the Activation of Innate Immune Pattern-Recognition Receptor RIG-I by Viral RNA
- (2011) Eva Kowalinski et al. CELL
- Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response
- (2011) I. Glowacka et al. JOURNAL OF VIROLOGY
- Dynamic Innate Immune Responses of Human Bronchial Epithelial Cells to Severe Acute Respiratory Syndrome-Associated Coronavirus Infection
- (2010) Tomoki Yoshikawa et al. PLoS One
- Differential Downregulation of ACE2 by the Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus and Human Coronavirus NL63
- (2009) I. Glowacka et al. JOURNAL OF VIROLOGY
- Angiotensin II infusion in man is proinflammatory but has no short-term effects on thrombin generation in vivo
- (2009) M. Ekholm et al. THROMBOSIS RESEARCH
- The discovery of angiotensin-converting enzyme 2 and its role in acute lung injury in mice
- (2008) Yumiko Imai et al. EXPERIMENTAL PHYSIOLOGY
- Modulation of TNF- -converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF- production and facilitates viral entry
- (2008) S. Haga et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More